Generic medicine
Daclatasvir
Daclatasvir · ATC J05 · Anti-infectives · Antivirals
Data statusRegistration & price fields require source verification.
30brand families
53registered presentations
30companies
53with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.| Brand | Manufacturer | Registered presentations |
|---|---|---|
| Declar2 presentations | Helix Pharma (Pvt)., Ltd. | |
| Declawin1 presentation | Shaigan Pharmaceuticals (Pvt) Ltd |
|
| DEVAZO2 presentations | SAMI Pharmaceuticals Pvt. Ltd. | |
| Dowdacla2 presentations | Martin Dow Limited | |
| Glinza1 presentation | Global Pharmaceuticals (Pvt.) Ltd. |
|
| Latvir1 presentation | Neutro Pharma (Pvt.) Ltd., |
|
| Livanza2 presentations | The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd. | |
| Maclinza2 presentations | Macter International Limited | |
| MYDEKLA2 presentations | AGP Limited | |
| NISITA1 presentation | TABROS PHARMA (PVT). LTD. |
|
Price movement
Official price changes for Daclatasvir
7 official price changes across 53 tracked presentations since 1 Jul 2024; median change +4.9%; largest +4.9% (Dac 60 mg)
Each dot is one DRAP-notified price change for one pack. Amber: increase; teal: decrease. Hover or tap for detail; click to open the brand.
| Brand | Pack | Effective | Old to new | Change |
|---|---|---|---|---|
| Dac 60 mg | 28's | 17 Aug 2026 | PKR 8,009.96 to 8,405.66 | +4.9% |
| Declawin 60 mg | 28's | 18 Aug 2026 | PKR 8,009.96 to 8,405.66 | +4.9% |
| Dascot 60 mg | 28’s | 20 Aug 2026 | PKR 8,421.68 to 8,837.71 | +4.9% |
| Dac 30 mg | 28's | 17 Aug 2026 | PKR 4,895.37 to 5,137.20 | +4.9% |
| Dascot 30 mg | 28's | 20 Aug 2026 | PKR 4,895.37 to 5,137.20 | +4.9% |
| Daclawil 60 mg | 28's | 1 Jul 2025 | PKR 7,766.11 to 8,009.97 | +3.1% |
| Daclawil 30 mg | 28's | 1 Jul 2025 | PKR 4,746.33 to 4,895.36 | +3.1% |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.
Cite this record
Molecule record · ATC J05MedInfoBase. (2026). Daclatasvir — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/generic/daclatasvir/ ATC J05.
MedInfoBase. Daclatasvir — registered brands and price distribution in Pakistan [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 24]. Available from: https://medinfobase.com/generic/daclatasvir/ ATC J05.
MedInfoBase (2026) Daclatasvir — registered brands and price distribution in Pakistan. Available at: https://medinfobase.com/generic/daclatasvir/ (Accessed: 24 September 2026).
"Daclatasvir — registered brands and price distribution in Pakistan." MedInfoBase, 2026, https://medinfobase.com/generic/daclatasvir/. Accessed 24 Sep 2026.
MedInfoBase. 2026. "Daclatasvir — registered brands and price distribution in Pakistan." Accessed September 24, 2026. https://medinfobase.com/generic/daclatasvir/.
Records change over time. Please cite the access date so readers can locate the version you used.
